GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 678 filers reported holding GLAXOSMITHKLINE PLC in Q4 2013. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $256,000 | +1.6% | 5,575 | +18.2% | 0.18% | +3.5% |
Q2 2014 | $252,000 | 0.0% | 4,715 | -0.2% | 0.17% | -1.7% |
Q1 2014 | $252,000 | 0.0% | 4,725 | 0.0% | 0.17% | -0.6% |
Q4 2013 | $252,000 | +12.0% | 4,725 | +5.6% | 0.18% | +5.4% |
Q3 2013 | $225,000 | -35.0% | 4,475 | -35.4% | 0.17% | -22.1% |
Q2 2013 | $346,000 | – | 6,925 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |